Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
Hand-out
Press Releases
Crescent Biopharma  
November 12, 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1 bispecific antibody in development for treating solid tumors

avatar profile Olean Times Herald

Olean Times Herald


Local & Social